REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >

BNSSG Paediatric Joint Formulary

2.6 Hyperlipidaemia

Last edited: 15-01-2024

2.6 Hyperlipidaemia

First line drugs Second line drugs Specialist drugs Secondary care drugs

Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility

Lipid-regulating Drugs

 

Bile Acid Sequestrants

Colestyramine (TLS Amber specialist initiated)

 

Cholesterol Absorption Inhibitors

Ezetimibe (TLS Amber specialist initiated)

 

Fibrates

Fenofibrate (micronised or modified-release) (TLS Amber specialist initiated)

Bezafibrate (TLS Amber specialist initiated)

 

Statins 

Atorvastatin (TLS Amber specialist initiated)

Rosuvastatin (TLS Amber specialist initiated)

Simvastatin (TLS Amber specialist initiated)

Pravastatin (TLS Amber specialist initiated)